PMC:7247521 / 27534-27765 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T345","span":{"begin":4,"end":8},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T346","span":{"begin":54,"end":63},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T347","span":{"begin":79,"end":85},"obj":"UBERON:0000479"},{"id":"T348","span":{"begin":99,"end":105},"obj":"UBERON:0000479"},{"id":"T349","span":{"begin":120,"end":126},"obj":"UBERON:0001969"},{"id":"T350","span":{"begin":208,"end":223},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"The drug distribution results showed that most of the compounds distributed in tissue (VDss\u003e 0.45: tissue, VDss \u003c−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T87","span":{"begin":79,"end":85},"obj":"Body_part"},{"id":"T88","span":{"begin":99,"end":105},"obj":"Body_part"},{"id":"T89","span":{"begin":120,"end":126},"obj":"Body_part"}],"attributes":[{"id":"A87","pred":"fma_id","subj":"T87","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A89","pred":"fma_id","subj":"T89","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"The drug distribution results showed that most of the compounds distributed in tissue (VDss\u003e 0.45: tissue, VDss \u003c−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T25","span":{"begin":79,"end":85},"obj":"Body_part"},{"id":"T26","span":{"begin":99,"end":105},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"The drug distribution results showed that most of the compounds distributed in tissue (VDss\u003e 0.45: tissue, VDss \u003c−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T222","span":{"begin":120,"end":126},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"The drug distribution results showed that most of the compounds distributed in tissue (VDss\u003e 0.45: tissue, VDss \u003c−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T168","span":{"begin":4,"end":8},"obj":"Chemical"}],"attributes":[{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"The drug distribution results showed that most of the compounds distributed in tissue (VDss\u003e 0.45: tissue, VDss \u003c−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target."}

{"project":"LitCovid-sentences","denotations":[{"id":"T197","span":{"begin":0,"end":231},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The drug distribution results showed that most of the compounds distributed in tissue (VDss\u003e 0.45: tissue, VDss \u003c−0.15: plasma) with good unbound fraction scores, thus becoming available to interact with the pharmacological target."}